{
    "Trade/Device Name(s)": [
        "IgX PLEX\u2122 Celiac Qualitative Assay"
    ],
    "Submitter Information": "SQI Diagnostics Systems Inc.",
    "510(k) Number": "K102490",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042644"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MVM"
    ],
    "Summary Letter Date": "May 27, 2011",
    "Summary Letter Received Date": "May 31, 2011",
    "Submission Date": "April 7, 2011",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "anti-tissue transglutaminase antibody (IgA)",
        "anti-tissue transglutaminase antibody (IgG)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SQiDworks\u2122 Diagnostics Platform"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex immunoassay",
        "Enzyme-linked immunosorbent assay (ELISA)",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Multiplexed immunoassay",
        "Automated immunoassay",
        "Fluorescent microarray"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent Kit",
        "Platform"
    ],
    "Document Summary": "FDA 510(k) summary for SQI Diagnostics IgX PLEX Celiac Qualitative Assay, an automated multiplex immunoassay for qualitative detection of anti-tissue transglutaminase IgA and IgG antibodies as an aid in diagnosing celiac disease.",
    "Indications for Use Summary": "For qualitative detection of IgA and IgG anti-tissue transglutaminase antibodies in serum, as an aid in the diagnosis of celiac disease in clinical laboratories, requiring the SQiDworks Diagnostics Platform.",
    "fda_folder": "Immunology"
}